-
Access to Healthcare
Going upstream to improve heart health in Philadelphia
Cardiovascular disease is the leading cause of death in the US, claiming one in four lives. Social factors such as living conditions, education and diet play a key role in determining a person’s heart health, which means cardiovascular disease typically hits vulnerable communities the hardest. Our three-year Closing the Gap initiative with the Jefferson Collaborative for Health Equity (established by Jefferson Health and Thomas Jefferson University) focuses on addressing the upstream social determinants of heart health in five vulnerable neighborhoods in Philadelphia with high rates of stroke and adverse outcomes related to heart disease.
Access to Healthcare -
Patient Perspectives
A cancer patient gets a new lease on life
After being diagnosed with advanced prostate cancer, Van Lacour received a Novartis radioligand therapy as part of a managed access program in 2021. Today, he is living a fulfilling life in his hometown of Natchez, Louisiana, US.
Patient Perspectives -
Access to HealthcareAccess to HealthcareClinical ResearchEthical BusinessMedicine Safety
Compassionate use: Providing access to much needed treatments
What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, we are providing a lifeline of access to innovative medicines under review or not yet approved locally when no other treatment options are available.
Access to Healthcare -
Patient Perspectives
Prostate cancer and support of the care partner – Carl and Arlene’s story
When Carl was diagnosed with metastatic prostate cancer, he and his wife Arlene began navigating his cancer journey while still looking to enjoy their retirement – hoping to remain active with family and friends in their retirement community.
Patient Perspectives -
People and CultureBiomedical ResearchNovartis Institutes for BioMedical ResearchScientific ResearchDrug DevelopmentWomen in Science
A scientist from the start – Q&A with NIBR President Fiona Marshall
People and Culture -
People and CultureDrug DiscoveryNeurodegenerative DiseaseNeuroscienceNovartis Institutes for BioMedical ResearchScientific Research
In neuroscience, “an inflection point in knowledge and technology”
People and Culture -
Patient PerspectivesCancerOncologyPatient Voices
Let’s Talk About the C Word: Navigating a cancer diagnosis and the life beyond it with Leanne Pero
Leanne Pero discusses her experiences of life before, during and after breast cancer, and how it inspired her to advocate for herself and others like her.
Patient Perspectives -
Access to HealthcareAccess to HealthcareClinical ResearchDrug DevelopmentInfectious DiseasesTropical Diseases
Renewing our commitment to neglected tropical disease and malaria elimination
Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.
Access to Healthcare -
Access to HealthcareAccess to HealthcareAfricaChildren's HealthNovartis Access
Sickle cell screening urged for newborns in Africa
Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.
Access to Healthcare -
DiscoveryCancerDrug DiscoveryNovartis Institutes for BioMedical ResearchOncologyWomen in Science
A shared mission to take on the “impossible” in cancer research
Discovery -
Access to HealthcareAccess to HealthcareCancerOncologySocial CommitmentTargeted Therapy
Prostate Cancer: A collective commitment to serving underserved communities
Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.
Access to Healthcare -
DiscoveryCancerCell and Gene TherapyChildren's HealthNovartis Institutes for BioMedical ResearchOncology
How Emily’s act of bravery inspired a wave of continued innovation
Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.
Discovery
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 33
- › Next page